Drug treatment of lipid disorders.
Knopp
R H
RH
Northwest Lipid Research Clinic, University of Washington School of Medicine, Seattle, USA.
D000837:Anion Exchange Resins / Q000009:adverse effects / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology; D002994:Clofibrate / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000150:complications / Q000178:diet therapy / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009525:Niacin / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors
D000837:Anion Exchange Resins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D009525:Niacin; D002994:Clofibrate